Legal & General Group PLC Roivant Sciences Ltd. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Legal & General Group PLC holds 549,329 shares of ROIV stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

549,329

Previous 611,156 10.12%

Holding current value

$11.1 Million

Previous $6.89 Million 20.68%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$10.74 - $15.28 $664,021 - $944,716	-61,827 Reduced 10.12%	549,329 $8.31 Million
Q2 2025 Aug 12, 2025	SELL	$9.08 - $11.62 $29,727 - $38,043	-3,274 Reduced 0.53%	611,156 $6.89 Million
Q1 2025 May 15, 2025	BUY	$10.09 - $12.08 $116,761 - $139,789	11,572 Added 1.92%	614,430 $6.2 Million
Q4 2024 Feb 13, 2025	SELL	$11.16 - $12.71 $430,597 - $490,402	-38,584 Reduced 6.02%	602,858 $7.13 Million
Q3 2024 Feb 28, 2025	BUY	$10.17 - $12.5 $27,764 - $34,125	2,730 Added 0.45%	605,588 $6.99 Million

Q3 2024 Nov 14, 2024	BUY	$10.17 - $12.5 $735,270 - $903,725	72,298 Added 12.7%	641,442 $7.4 Million
Q2 2024 May 29, 2025	BUY	$10.36 - $11.74 $1.03 Million - $1.16 Million	98,950 Added 22.78%	533,290 $5.64 Million
Q2 2024 Aug 14, 2024	BUY	$10.36 - $11.74 $1.4 Million - $1.58 Million	134,804 Added 31.04%	569,144 $6.02 Million
Q1 2024 May 29, 2025	SELL	$9.87 - $11.8 $1.78 Million - $2.13 Million	-180,090 Reduced 29.31%	434,340 $4.58 Million
Q1 2024 May 14, 2024	BUY	$9.87 - $11.8 $1.39 Million - $1.66 Million	140,375 Added 47.75%	434,340 $4.58 Million
Q4 2023 May 29, 2025	SELL	$8.38 - $11.58 $2.69 Million - $3.71 Million	-320,465 Reduced 52.16%	293,965 $3.3 Million
Q4 2023 Feb 15, 2024	SELL	$8.38 - $11.58 $9,704 - $13,409	-1,158 Reduced 0.39%	293,965 $3.3 Million
Q3 2023 Nov 14, 2023	SELL	$9.76 - $13.19 $311,939 - $421,565	-31,961 Reduced 9.77%	295,123 $3.45 Million
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $1.49 Million - $2.12 Million	210,001 Added 179.36%	327,084 $3.3 Million
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $107,868 - $155,568	15,588 Added 15.36%	117,083 $864,000
Q4 2022 Feb 14, 2023	BUY	$3.36 - $7.99 $12,022 - $28,588	3,578 Added 3.65%	101,495 $810,000
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $49,937 - $473,918	97,917 New	97,917 $315,000

Others Institutions Holding ROIV

# of Institutions

376

Shares Held

436M

Call Options Held

6.03M

Put Options Held

2.52M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $14.3B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Roivant Sciences Ltd. Transaction History